companies / atommapper-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-05 json
| total_raised | 59,630,32859.6M | ○ |
|---|---|---|
| founded | null | |
| hq | New York, New York | |
| industry | unknown | |
| stage | null |
Fathom Therapeutics, formerly Atommap, uses quantum chemistry and AI to design small-molecule drugs by simulating protein motion at atomic resolution. It serves drug discovery through an internal pipeline and partnerships.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-03-20 | Funding round | 59,630,32859.6M | null | ○ |
astro 6.1.7, hsts, vercel
| fact | status | src |
|---|---|---|
| Funding round, $59.6M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $59.6M, 2026-03-20 → Funding round, $59.6M, 2026-03-20, ○ 2026-06-05 | latest_round | seed, $59.6M, 2026-03-20 → Funding round, $59.6M, 2026-03-20 | ○ 2026-06-05 |
Records begin 2026-09-24. all_changes